BioRestorative Therapies Statistics
Total Valuation
BRTX has a market cap or net worth of $15.01 million. The enterprise value is $5.90 million.
Important Dates
The last earnings date was Wednesday, May 14, 2025, after market close.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BRTX has 7.50 million shares outstanding. The number of shares has increased by 65.13% in one year.
| Current Share Class | 7.50M |
| Shares Outstanding | 7.50M |
| Shares Change (YoY) | +65.13% |
| Shares Change (QoQ) | +2.85% |
| Owned by Insiders (%) | 19.17% |
| Owned by Institutions (%) | 3.76% |
| Float | 4.92M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 41.87 |
| Forward PS | 6.28 |
| PB Ratio | 2.45 |
| P/TBV Ratio | 2.71 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 15.08 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.24
| Current Ratio | 2.24 |
| Quick Ratio | 2.19 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -117.16% and return on invested capital (ROIC) is -73.74%.
| Return on Equity (ROE) | -117.16% |
| Return on Assets (ROA) | -54.16% |
| Return on Invested Capital (ROIC) | -73.74% |
| Return on Capital Employed (ROCE) | -199.41% |
| Revenue Per Employee | $35,545 |
| Profits Per Employee | -$1.10M |
| Employee Count | 11 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +70.94% in the last 52 weeks. The beta is 76.56, so BRTX's price volatility has been higher than the market average.
| Beta (5Y) | 76.56 |
| 52-Week Price Change | +70.94% |
| 50-Day Moving Average | 1.75 |
| 200-Day Moving Average | 1.73 |
| Relative Strength Index (RSI) | 71.39 |
| Average Volume (20 Days) | 185,297 |
Short Selling Information
The latest short interest is 141,777, so 1.89% of the outstanding shares have been sold short.
| Short Interest | 141,777 |
| Short Previous Month | 163,297 |
| Short % of Shares Out | 1.89% |
| Short % of Float | 2.88% |
| Short Ratio (days to cover) | 5.20 |
Income Statement
In the last 12 months, BRTX had revenue of $391,000 and -$12.10 million in losses. Loss per share was -$1.48.
| Revenue | 391,000 |
| Gross Profit | 360,019 |
| Operating Income | -12.25M |
| Pretax Income | -6.96M |
| Net Income | -12.10M |
| EBITDA | -12.06M |
| EBIT | -12.25M |
| Loss Per Share | -$1.48 |
Full Income StatementBalance Sheet
The company has $9.11 million in cash and n/a in debt, giving a net cash position of $9.11 million or $1.21 per share.
| Cash & Cash Equivalents | 9.11M |
| Total Debt | n/a |
| Net Cash | 9.11M |
| Net Cash Per Share | $1.21 |
| Equity (Book Value) | 6.14M |
| Book Value Per Share | 0.82 |
| Working Capital | 5.17M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$8.69 million and capital expenditures -$142,589, giving a free cash flow of -$8.83 million.
| Operating Cash Flow | -8.69M |
| Capital Expenditures | -142,589 |
| Free Cash Flow | -8.83M |
| FCF Per Share | -$1.18 |
Full Cash Flow StatementMargins
| Gross Margin | 92.08% |
| Operating Margin | -3,133.88% |
| Pretax Margin | -3,093.59% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BRTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -65.13% |
| Shareholder Yield | -65.13% |
| Earnings Yield | -80.59% |
| FCF Yield | -58.86% |
Analyst Forecast
The average price target for BRTX is $18.00, which is 800.00% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $18.00 |
| Price Target Difference | 800.00% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 256.89% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 27, 2021. It was a reverse split with a ratio of 0.00025:1.
| Last Split Date | Oct 27, 2021 |
| Split Type | Reverse |
| Split Ratio | 0.00025:1 |
Scores
BRTX has an Altman Z-Score of -23.49 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -23.49 |
| Piotroski F-Score | 2 |